• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国耐多药结核病患者治疗结局相关因素的回顾性研究:采用竞争风险模型。

Factors associated with treatment outcomes of patients with drug-resistant tuberculosis in China: A retrospective study using competing risk model.

机构信息

Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China.

Department of Tuberculosis Control and Prevention, Guangzhou Chest Hospital, Guangzhou, China.

出版信息

Front Public Health. 2022 Sep 7;10:906798. doi: 10.3389/fpubh.2022.906798. eCollection 2022.

DOI:10.3389/fpubh.2022.906798
PMID:36159235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9490188/
Abstract

OBJECTIVES

Drug-resistant tuberculosis remains a serious public health problem worldwide, particularly in developing countries, including China. This study determined treatment outcomes among a cohort in Guangzhou, China, and identified factors associated with them.

METHODS

We initiated a retrospective study using drug-resistant TB data in Guangzhou from 2016 to 2020, managed by Guangzhou Chest Hospital. A competing risk model was used to identify the factors associated with treatment failure and death, as well as loss to follow-up (LTFU).

RESULTS

A total of 809 patients were included in the study, of which 281 were under treatment. Of the remaining 528 who had clear treatment outcomes, the number and proportion of treatment success, treatment failure, death, and LTFU were 314 (59.5%), 14 (2.7%), 32 (6.0%), and 168 (31.8%), respectively. Being older and having cavities involving the upper lungs were risk factors for treatment failure and death, while non-Guangzhou household registration and interprovincial mobility were risk factors associated with LTFU.

CONCLUSION

Treatment failure and death were significantly associated with cavitation in the lungs, and LTFU was significantly associated with household registration and geographical mobility. Early identification of factors associated with different treatment outcomes is extremely important for policymakers, health experts, and researchers to implement appropriate strategies and measures to treat and manage the TB-infected population in China.

摘要

目的

耐药结核病仍然是全球范围内一个严重的公共卫生问题,尤其是在包括中国在内的发展中国家。本研究旨在确定中国广州某队列的治疗结果,并确定与这些结果相关的因素。

方法

我们利用广州胸科医院管理的 2016 年至 2020 年广州耐药结核病数据开展了一项回顾性研究。采用竞争风险模型确定与治疗失败和死亡以及失访(LTFU)相关的因素。

结果

本研究共纳入 809 例患者,其中 281 例正在接受治疗。在其余 528 例治疗结局明确的患者中,治疗成功、治疗失败、死亡和 LTFU 的例数和比例分别为 314 例(59.5%)、14 例(2.7%)、32 例(6.0%)和 168 例(31.8%)。年龄较大和上肺有空洞是治疗失败和死亡的危险因素,而非广州户籍和省际流动是 LTFU 的危险因素。

结论

治疗失败和死亡与肺部空洞显著相关,LTFU 与户籍和地域流动显著相关。早期识别与不同治疗结果相关的因素对于政策制定者、卫生专家和研究人员实施适当的策略和措施来治疗和管理中国的结核感染人群至关重要。

相似文献

1
Factors associated with treatment outcomes of patients with drug-resistant tuberculosis in China: A retrospective study using competing risk model.中国耐多药结核病患者治疗结局相关因素的回顾性研究:采用竞争风险模型。
Front Public Health. 2022 Sep 7;10:906798. doi: 10.3389/fpubh.2022.906798. eCollection 2022.
2
Isoniazid mono-resistant tuberculosis: Time to take it seriously.异烟肼单耐药结核病:是时候认真对待了。
Indian J Tuberc. 2019 Apr;66(2):247-252. doi: 10.1016/j.ijtb.2019.04.001. Epub 2019 Apr 9.
3
Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study.在埃塞俄比亚西北部贡德尔大学综合专科医院,耐多药结核病患者失访的发生率和预测因素:一项回顾性随访研究。
BMC Infect Dis. 2019 Sep 18;19(1):817. doi: 10.1186/s12879-019-4447-8.
4
Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects.耐药结核病患者失访的决定因素:心理社会和经济方面的重要性。
BMC Pulm Med. 2021 Nov 10;21(1):360. doi: 10.1186/s12890-021-01735-9.
5
Predictors of loss to follow-up among adult tuberculosis patients in Southern Ethiopia: a retrospective follow-up study.埃塞俄比亚南部地区成人肺结核患者失访的预测因素:一项回顾性随访研究。
BMC Public Health. 2022 May 14;22(1):976. doi: 10.1186/s12889-022-13390-8.
6
What happened to patients with RMP-resistant/MDR-TB in Zambia reported as lost to follow-up from 2011 to 2014?2011年至2014年期间,赞比亚报告的对利福平耐药/耐多药结核病患者失访情况如何?
Int J Tuberc Lung Dis. 2017 Aug 1;21(8):887-893. doi: 10.5588/ijtld.16.0933.
7
Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands.荷兰常规治疗儿童和青少年结核病的治疗结果的全国性分析。
Eur Respir J. 2019 Dec 12;54(6). doi: 10.1183/13993003.01402-2019. Print 2019 Dec.
8
National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study.国家治疗结局和埃塞俄比亚耐多药结核病死亡和治疗失败的预测因素:一项 10 年回顾性队列研究。
BMJ Open. 2021 Aug 10;11(8):e040862. doi: 10.1136/bmjopen-2020-040862.
9
Assessment of Factors Associated with Unfavorable Outcomes among Drug-Resistant TB Patients: A 6-Year Retrospective Study from Pakistan.耐药结核病患者不良结局相关因素评估:来自巴基斯坦的一项 6 年回顾性研究。
Int J Environ Res Public Health. 2022 Jan 29;19(3):1574. doi: 10.3390/ijerph19031574.
10
Rifampicin-resistant tuberculosis patients in Myanmar in 2016: how many are lost on the path to treatment?2016 年缅甸耐利福平结核病患者:有多少人在治疗道路上流失?
Int J Tuberc Lung Dis. 2018 Apr 1;22(4):385-392. doi: 10.5588/ijtld.17.0452.

引用本文的文献

1
Predicting Treatment Outcomes in Patients with Drug-Resistant Tuberculosis and Human Immunodeficiency Virus Coinfection, Using Supervised Machine Learning Algorithm.使用监督式机器学习算法预测耐多药结核病与人类免疫缺陷病毒合并感染患者的治疗结果
Pathogens. 2024 Oct 24;13(11):923. doi: 10.3390/pathogens13110923.
2
Prevalence and risk factors of anxiety and depression in patients with multi-drug/rifampicin-resistant tuberculosis.耐多药/利福平耐药结核病患者的焦虑和抑郁患病率及相关因素。
Front Public Health. 2024 Mar 27;12:1372389. doi: 10.3389/fpubh.2024.1372389. eCollection 2024.

本文引用的文献

1
Tuberculosis Treatment Outcomes and Associated Factors Among Patients Treated at Woldia General Hospital in Northeast Ethiopia: An Institution-Based Cross-Sectional Study.埃塞俄比亚东北部沃尔迪亚综合医院结核病治疗结果及其相关因素:一项基于机构的横断面研究
Infect Drug Resist. 2020 Oct 6;13:3423-3429. doi: 10.2147/IDR.S275568. eCollection 2020.
2
Competing risk of mortality on loss to follow-up outcome among patients with HIV on ART: a retrospective cohort study from the Zimbabwe national ART programme.接受抗逆转录病毒治疗的艾滋病毒患者失访结局的死亡竞争风险:来自津巴布韦国家抗逆转录病毒治疗项目的一项回顾性队列研究。
BMJ Open. 2020 Oct 6;10(10):e036136. doi: 10.1136/bmjopen-2019-036136.
3
Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis.
耐多药结核病和 HIV 成人的死亡率与抗逆转录病毒治疗和抗结核药物使用情况:一项个体患者数据荟萃分析。
Lancet. 2020 Aug 8;396(10248):402-411. doi: 10.1016/S0140-6736(20)31316-7.
4
Household financial burden among multidrug-resistant tuberculosis patients in Guizhou province, China: A cross-sectional study.中国贵州省耐多药结核病患者的家庭经济负担:一项横断面研究。
Medicine (Baltimore). 2020 Jul 10;99(28):e21023. doi: 10.1097/MD.0000000000021023.
5
Epidemic Trends of Tuberculosis in China from 1990 to 2017: Evidence from the Global Burden of Disease Study.1990年至2017年中国结核病流行趋势:基于全球疾病负担研究的证据
Infect Drug Resist. 2020 Jun 9;13:1663-1672. doi: 10.2147/IDR.S249698. eCollection 2020.
6
Cavitary tuberculosis: the gateway of disease transmission.空洞性肺结核:疾病传播的门户。
Lancet Infect Dis. 2020 Jun;20(6):e117-e128. doi: 10.1016/S1473-3099(20)30148-1. Epub 2020 May 5.
7
Modeling and dynamic analysis of tuberculosis in mainland China from 1998 to 2017: the effect of DOTS strategy and further control.中国大陆 1998 年至 2017 年结核病建模与动态分析:DOTS 策略与进一步控制的效果。
Theor Biol Med Model. 2020 May 4;17(1):6. doi: 10.1186/s12976-020-00124-9.
8
Epidemiology of drug-resistant tuberculosis in Chongqing, China: A retrospective observational study from 2010 to 2017.中国重庆耐药结核病的流行病学:2010 年至 2017 年的回顾性观察研究。
PLoS One. 2019 Dec 10;14(12):e0216018. doi: 10.1371/journal.pone.0216018. eCollection 2019.
9
Drug Non-Adherence And Reasons Among Multidrug-Resistant Tuberculosis Patients In Guizhou, China: A Cross-Sectional Study.中国贵州耐多药结核病患者的药物不依从性及其原因:一项横断面研究
Patient Prefer Adherence. 2019 Sep 30;13:1641-1653. doi: 10.2147/PPA.S219920. eCollection 2019.
10
Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients.分析 4099 例耐多药肺结核患者的失访情况。
Eur Respir J. 2019 Jul 11;54(1). doi: 10.1183/13993003.00353-2018. Print 2019 Jul.